Social commitment
Acting responsibly
Like the entire Bayer Group, Bayer Schering Pharma sees itself as a corporate citizen, as a company that is part of society with an obligation to behave in a socially responsible manner.
This obligation applies to the products we develop, produce and sell. They help improve people's quality of life by improving the diagnosis and treatment of illnesses.
This obligation goes even further: in view of the great inequality of opportunities in the world, we as a researching pharmaceutical company support many different projects aimed at bridging the differences in medical care.
Support for patient advocacy groups
Bayer Schering Pharma is committed to developing new and innovative therapies for severe and chronic diseases. Patient advocacy groups and other voluntary health organisations help increase disease awareness and effective interventions.
The patient and voluntary health organisations to which Bayer Schering Pharma provided financial support from July to December 2007 are as follows:
Brook - £3,800
Cancer Research UK - £9,000
Cancerbackup - £11,000
Family Planning Association - £4,680
Haemophilia Society - £30,000
Life Blood - £15,000
Lymphoma Association - £15,060
MacMillan Cancer Support - £4,620
MS Society - £114,000
Myeloma UK - £12,000
Rarer Cancers Forum - £28,050.62
Royal College of Obstetricians & Gynaecologists - £20,000
Pituitary Foundation - £9,000
Sexual Dysfunction Association - £7,000
This information will be updated again by 1st July 2008.
